Clinical Trials Browser

Phase 2 × Active not recruiting × Folfox protocol × Clear all

NCT06106308 2026-01-12

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04595266 2025-09-29

LIVERPEARL

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05712356 2025-06-06

BOLSTER

Phase 2 Active not recruiting

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT03548961 2025-04-04

Organ Preservation in Early Rectal Cancer Patients

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

NCT05864105 2025-03-12

PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT03781323 2024-12-13

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

Phase 2 Active not recruiting

12 enrolled 9 charts

Gastrointestinal

Advanced Rectal Cancer